A retrospective study to evaluate the alterations of hematogenesis and bone mineral density after dutasteride treatment in aged patients with benign prostatic hyperplasia.
Phase of Trial: Phase IV
Latest Information Update: 18 Aug 2015
At a glance
- Drugs Dutasteride (Primary)
- Indications Benign prostatic hyperplasia
- Focus Therapeutic Use
- 18 Aug 2015 New trial record